Aman Godara

[Nauman Saleem Siddiqui, MD MPH FACP @HemOnc_AI]

https://t.co/nc9n4DXDb4
@amangodaramd

[CAMP@CUIMC @CAMPamyloidosis]

More data from @TuftsMedicalCtr and @sloan_kettering on importance of post-treatment iFLC in AL #Amyloidosis: The lower, the better!! https://t.co/fopKLPYSgf @AmyloidosisSupp

[Kidney Medicine @KidneyMed]

Transplant-Associated Thrombotic Microangiopathy in a Patient With Polycystic Kidney Disease Immediately Post–Kidney Transplant: A Case Report

https://t.co/s4c5xXUK74 #OpenAccess

@niten24 @Gordon7Craig @TuftsMedicalCtr #kidneytransplant #PKD

[Journal of Clinical Oncology @JCO_ASCO]

Stem-cell source, acute GVHD, infections, and hospital size most significant factors associated with LOS for allogenic stem-cell transplant https://t.co/qtej3P9DMR #JCOOP

[Aman Godara @amangodaramd]

Just out. We analyzed inpatient transplant outcomes and factors predicting variations in hospital stay for allo-transplant @kansagraMD @RishiDhawanPGI

[Nauman Saleem Siddiqui, MD MPH FACP @HemOnc_AI]

https://t.co/gm0Hy9e6kC
Congratulations to @amangodaramd and the team

JCO Oncology Practice

Length of Stay and Hospital Costs for Patients Undergoing Allogeneic Stem-Cell Transplantation

[Aman Godara @amangodaramd]

Fruit of labor from 1st year of fellowship!!!

[Nauman Saleem Siddiqui, MD MPH FACP @HemOnc_AI]

Prospective Evaluation of Effect of Metformin on Activation of AMP-activated Protein Kinase (AMPK) and Disease Cont… https://t.co/1VL2jOhsGH
@WasifSaifMD @amangodaramd

[Nauman Saleem Siddiqui, MD MPH FACP @HemOnc_AI]

#ASH19 #MachineLearning Using ML algorithms and state level data base to predict acute myeloid leukemia treatment related in hospital mortality, independent of type of chemotherapy, performance status and disease characteristics.

[Andrew Rezvani @AndrewRezvani]

Interesting story in the Times about the forensic implications of hematopoietic cell transplantation... although one of the experts they quoted sounds pretty dodgy. 😇

https://t.co/1yXUBfYiX0

[Nauman Saleem Siddiqui, MD MPH FACP @HemOnc_AI]

Congratulations @amangodaramd for the 3rd consecutive oral presentation at #TCT #ASTCT #Legacy #tradition @AndreasKleinMD @BldCancerDoc @HilalHachem @DrAEvens @WasifSaifMD @SaurabhDahiyaMD

[Aman Godara @amangodaramd]

Big guns at ASTCT19 #gun show @ same convention center #onlyinTexas

[Aman Godara @amangodaramd]

Congrats Tania!!

[Gunjan Shah @GunjanLShah]

Congrats Tsoni and Tania!! @tsonipeled @TaniaJain11 #TCTM19 #MSKCC

[Aman Godara @amangodaramd]

#ASTCT19 President @iNDUSBMT dinner

[Aman Godara @amangodaramd]

@BldCancerDoc @ASBMT Congratulations, looking forward to a great year under your leadership!!

[Nauman Saleem Siddiqui, MD MPH FACP @HemOnc_AI]

Congrats to Aman @myelomAman_md -2nd year in a row we had the opportunity to present our work at #TCTM19 @CIMBTR ASBMT Oral presentation, Poster ASCT - LOS Transplant related TTP

[Aman Godara @amangodaramd]

@GunjanLShah @AndreasKleinMD @TuftsMedicalCtr Thank you @GunjanLShah for sharing the pictures.

[Gunjan Shah @GunjanLShah]

Congrats Amandeep Godara on a great presentation on LOS using the NIS! @AndreasKleinMD @TuftsMedicalCtr

[Blood Journals Portfolio @BloodPortfolio]

Review Article: Myeloproliferative neoplasms: from origins to outcomes https://t.co/yyGdH5ebjE

[Tania Jain @TaniaJain11]

Is this the future (in addition to CARs ofcourse): Venetoclax + anything = better RR (except in Follicular😉)? #ASH17

[FDA Oncology @FDAOncology]

2017 a banner year for FDA approvals in hematologic malignancies. In this graphic, purple=4 new drug approvals for AML; red=5 new drugs for ALL/NHL; orange=supplemental approvals for new indications #ASH17